US Bancorp DE Has $28.19 Million Stock Holdings in Cigna Group $CI

US Bancorp DE lowered its holdings in shares of Cigna Group (NYSE:CIFree Report) by 4.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 97,807 shares of the health services provider’s stock after selling 4,348 shares during the period. US Bancorp DE’s holdings in Cigna Group were worth $28,193,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Harbor Capital Advisors Inc. boosted its holdings in shares of Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares in the last quarter. Collier Financial acquired a new position in shares of Cigna Group during the 3rd quarter valued at $34,000. NewSquare Capital LLC boosted its stake in Cigna Group by 38.8% during the second quarter. NewSquare Capital LLC now owns 143 shares of the health services provider’s stock worth $47,000 after acquiring an additional 40 shares in the last quarter. Traub Capital Management LLC acquired a new stake in Cigna Group in the second quarter worth $48,000. Finally, Access Investment Management LLC bought a new stake in Cigna Group in the second quarter valued at $49,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Trading Up 0.3%

Shares of Cigna Group stock opened at $289.73 on Friday. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock has a fifty day simple moving average of $279.98 and a 200 day simple moving average of $284.53. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a market capitalization of $77.39 billion, a P/E ratio of 13.06, a price-to-earnings-growth ratio of 1.00 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same period in the prior year, the firm posted $6.64 EPS. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s dividend payout ratio is currently 27.23%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. Jefferies Financial Group upped their price target on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. TD Cowen upped their target price on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Finally, Cantor Fitzgerald reduced their price target on shares of Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $330.63.

View Our Latest Stock Report on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.